Development code · Small Molecule
NSI-189
NSI-189 is a development code for ALTO-100 (amdiglurax), developed by Alto Neuroscience, Inc..
- Status
- Phase 2 for Bipolar depression
- Mechanism
- TLX Agonist
- Developer
- Alto Neuroscience, Inc.
Programs
- ALTO-100 (amdiglurax) for Bipolar depressionPhase 2Recruiting
Also known as
- ALTO-100
- amdiglurax